For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy

By sjmartinez • May 24, 2024

Silverstein J, Goyal N, Tsai KK. For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy. Curr Oncol Rep. 2024 May 23. doi: 10.1007/s11912-024-01541-6. Epub ahead of print. PMID: 38780676.

Tags: Fellow, Hematology/Oncology, Melanoma survivorship quality of life, Publications

Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy

Isaacs DJ, Kathuria-Prakash N, Hilder R, Lechner MG, Drakaki A. Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint[...]

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer

Bang YH, Lee CK, Bang K, Kim HD, Kim KP, Jeong JH, Park I, Ryoo BY, Lee DK, Choi HJ, Chung T, Jeon SH, Shin[...]

Feasibility of a blood pressure telemedicine program in the virtual age

Sreekrishnan A, Lansberg M, Singer AE, Tennant RS, Howard M, Buncom J, Castillo M, Rajasekhar V, Kraler L. Feasibility of a blood pressure telemedicine program[...]